Product Description
Fampridine is a drug that has been shown to improve walking speed for some adults with multiple sclerosis. (Sourced from: https://mstrust.org.uk/a-z/fampridine-fampyra)
Mechanisms of Action: Potassium Channel Blocker
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: *
Approval Status: Approved
Approved Countries: Argentina | Australia | Austria | Belgium | Brazil | Canada | Chile | Colombia | Croatia | Cyprus | Czech | Denmark | Dominican Republic | Ecuador | Egypt | Estonia | European Medicines Agency | Finland | France | Germany | Greece | Hungary | Iceland | India | Ireland | Israel | Italy | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malta | Netherlands | New Zealand | Norway | Peru | Poland | Portugal | Romania | Russia | Saudi Arabia | Slovakia | Slovenia | South Africa | Spain | Sweden | Switzerland | Turkey | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela
Approved Indications: None
Known Adverse Events: None
Company: Acorda
Company Location:
Company CEO: Ron Cohen
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count: 1
Recent & Upcoming Milestones
Highest Development Phases
Phase 2: Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
2020-002438-34 |
2020-002438-34 | P2 |
Completed |
Chronic Inflammatory Demyelinating Polyradiculoneuropathy |
2024-09-30 |
2025-06-05 |
Primary Completion Date|Study Completion Date|Treatments |
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
06/18/2025 |
News Article |
Dog Nearly Dies from Ingesting Multiple Sclerosis Medication |
|
04/01/2025 |
News Article |
Quantum BioPharma Announces Joint Clinical Study With Massachusetts General Hospital Scientists to Validate a Novel Positron Emission Tomography (PET) Imaging Technique to Monitor Demyelination In Multiple Sclerosis |
|
07/10/2024 |
News Article |
Merz Therapeutics Closes $185M Asset Purchase Agreement with Acorda Therapeutics |
|
04/15/2024 |
News Article |
Acorda Therapeutics Announces Delisting from Nasdaq |